1
|
Bradley AE, Wancket LM, Rinke M, Gruebbel MM, Saladino BH, Schafer K, Katsuta O, Garcia B, Chanut F, Hughes K, Nelson K, Himmel L, McInnes E, Schucker A, Uchida K. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Rabbit. J Toxicol Pathol 2021; 34:183S-292S. [PMID: 34712007 PMCID: PMC8544166 DOI: 10.1293/tox.34.183s] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for
Lesions Project (www.toxpath.org/inhand.asp) is a joint initiative of the Societies of
Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP) and North
America (STP) to develop an internationally accepted nomenclature for proliferative and
non-proliferative lesions in laboratory animals. The purpose of this publication is to
provide a standardized nomenclature for classifying microscopic lesions observed in most
tissues and organs from the laboratory rabbit used in nonclinical safety studies. Some of
the lesions are illustrated by color photomicrographs. The standardized nomenclature
presented in this document is also available electronically on the internet
(http://www.goreni.org/). Sources of material included histopathology databases from
government, academia, and industrial laboratories throughout the world. Content includes
spontaneous lesions as well as lesions induced by exposure to test materials. Relevant
infectious and parasitic lesions are included as well. A widely accepted and utilized
international harmonization of nomenclature for lesions in laboratory animals will provide
a common language among regulatory and scientific research organizations in different
countries and increase and enrich international exchanges of information among
toxicologists and pathologists.
Collapse
Affiliation(s)
- Alys E Bradley
- Charles River Laboratories Edinburgh Ltd, Tranent, Scotland, UK
| | | | | | | | | | | | | | - Begonya Garcia
- Charles River Laboratories Edinburgh Ltd, Tranent, Scotland, UK
| | - Franck Chanut
- Sanofi, 1 Avenue Pierre Brosselette, 91380 Chilly-Mazarin, France
| | | | | | - Lauren Himmel
- Vanderbilt University Medical Center, Nashville, TN, USA
| | | | - Adrienne Schucker
- American Preclinical Services, LLC, 8945 Evergreen Blvd, Minneapolis, MN 55433
| | | |
Collapse
|
2
|
Booler HS, Lejeune T, Sorden S, Gruebbel MM, Schafer KA, Short B, Farman C, Ramos MF, Bennet B, Yekkala K, Atzpodien EA, Turner OC, Brassard J, Foley G. Scientific and Regulatory Policy Committee Points to Consider: Fixation, Trimming, and Sectioning of Nonrodent Eyes and Ocular Tissues for Examination in Ocular and General Toxicity Studies. Toxicol Pathol 2021; 50:235-251. [PMID: 34693851 DOI: 10.1177/01926233211047562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A Working Group of the Society of Toxicologic Pathology's Scientific and Regulatory Policy Committee conducted a technical and scientific review of current practices relating to the fixation, trimming, and sectioning of the nonrodent eye to identify key points and species-specific anatomical landmarks to consider when preparing and evaluating eyes of rabbits, dogs, minipigs, and nonhuman primates from ocular and general toxicity studies. The topics addressed in this Points to Consider article include determination of situations when more comprehensive evaluation of the globe and/or associated extraocular tissues should be implemented (expanded ocular sampling), and what constitutes expanded ocular sampling. In addition, this manuscript highlights the practical aspects of fixing, trimming, and sectioning the eye to ensure adequate histopathological evaluation of all major ocular structures, including the cone-dense areas (visual streak/macula/fovea) of the retina for rabbits, dogs, minipigs, and nonhuman primates, which is a current regulatory expectation for ocular toxicity studies.[Box: see text].
Collapse
Affiliation(s)
- Helen S Booler
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland
| | | | | | - Margarita M Gruebbel
- Experimental Pathology Laboratories, Inc. (EPL, Inc.), Research Triangle Park, NC, USA
| | | | - Brian Short
- Brian Short Consulting, LLC, Laguna Beach, CA, USA
| | | | | | | | - Krishna Yekkala
- Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, USA
| | - Elke-Astrid Atzpodien
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Switzerland
| | - Oliver C Turner
- Novartis, Novartis Institutes for BioMedical Research, Preclinical Safety, East Hanover, NJ, USA
| | | | | |
Collapse
|
3
|
Colman K, Andrews RN, Atkins H, Boulineau T, Bradley A, Braendli-Baiocco A, Capobianco R, Caudell D, Cline M, Doi T, Ernst R, van Esch E, Everitt J, Fant P, Gruebbel MM, Mecklenburg L, Miller AD, Nikula KJ, Satake S, Schwartz J, Sharma A, Shimoi A, Sobry C, Taylor I, Vemireddi V, Vidal J, Wood C, Vahle JL. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Non-proliferative and Proliferative Lesions of the Non-human Primate ( M. fascicularis). J Toxicol Pathol 2021; 34:1S-182S. [PMID: 34712008 PMCID: PMC8544165 DOI: 10.1293/tox.34.1s] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions Project (www.toxpath.org/inhand.asp) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP) and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying microscopic lesions observed in most tissues and organs from the nonhuman primate used in nonclinical safety studies. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the internet (http://www.goreni.org/). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes spontaneous lesions as well as lesions induced by exposure to test materials. Relevant infectious and parasitic lesions are included as well. A widely accepted and utilized international harmonization of nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.
Collapse
Affiliation(s)
- Karyn Colman
- Novartis Institutes for BioMedical Research, Cambridge, MA,
USA
| | - Rachel N. Andrews
- Wake Forest School of Medicine, Department of Radiation
Oncology, Winston-Salem, NC, USA
| | - Hannah Atkins
- Penn State College of Medicine, Department of Comparative
Medicine, Hershey, PA, USA
| | | | - Alys Bradley
- Charles River Laboratories Edinburgh Ltd., Tranent,
Scotland, UK
| | - Annamaria Braendli-Baiocco
- Roche Pharma Research and Early Development, Pharmaceutical
Sciences, Roche Innovation Center Basel, Switzerland
| | - Raffaella Capobianco
- Janssen Research & Development, a Division of Janssen
Pharmaceutica NV, Beerse, Belgium
| | - David Caudell
- Department of Pathology, Section on Comparative Medicine,
Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Mark Cline
- Department of Pathology, Section on Comparative Medicine,
Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Takuya Doi
- LSIM Safety Institute Corporation, Ibaraki, Japan
| | | | | | - Jeffrey Everitt
- Department of Pathology, Duke University School of
Medicine, Durham, NC, USA
| | | | | | | | - Andew D. Miller
- Cornell University College of Veterinary Medicine, Ithaca,
NY, USA
| | | | - Shigeru Satake
- Shin Nippon Biomedical Laboratories, Ltd., Kagoshima and
Tokyo, Japan
| | | | - Alok Sharma
- Covance Laboratories, Inc., Madison, WI, USA
| | | | | | | | | | | | - Charles Wood
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT,
USA
| | | |
Collapse
|
4
|
van Heerden M, Roosen W, Lachau-Durand S, Bailey G, Ndifor A. Exacerbation of Background Nuclear Cataracts in Sprague-Dawley Rats in Embryo-Fetal Development Studies With JNJ-42165279, a Fatty Acid Amide Hydrolase Inhibitor. Toxicol Pathol 2021; 49:1193-1205. [PMID: 34128434 DOI: 10.1177/01926233211010444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Fetal examinations in embryo-fetal developmental (EFD) studies are based on macroscopic and dissecting microscopic evaluations, and histopathology is rarely performed other than to confirm macroscopic findings. Fetal lens examination is therefore generally limited to the presence, size, shape, and color of any abnormality. In a Sprague-Dawley rat EFD study with the fatty acid amide hydrolase (FAAH) inhibitor JNJ-42165279, an unusually high incidence of macroscopic granular foci was noted within the lens of gestation day 21 fetuses across all groups including controls, with higher incidence in the high-dose group. On histological evaluation of the lenses from fetuses with/without gross findings, primary lens fiber hypertrophy (swelling) and degeneration were observed across vehicle- and JNJ-42165279-exposed fetuses. In a follow-up study to investigate the progression or resolution of the fetal lens changes, animals exposed to suprapharmacological doses of JNJ-42165279 in utero had higher incidence of nuclear cataracts as detected via slit-lamp ophthalmic examinations on postnatal days 18 to 21 and 35 to 41. No histologic correlates for these cataracts were identified. We conclude that fetal primary lens fiber hypertrophy and nuclear cataracts at ophthalmology, are common background changes in this rat strain that are exacerbated by in utero exposure to the FAAH inhibitor JNJ-42165279.
Collapse
Affiliation(s)
| | - Wendy Roosen
- 81828Janssen Research & Development, Beerse, Belgium
| | | | - Graham Bailey
- 81828Janssen Research & Development, Beerse, Belgium
| | - Anthony Ndifor
- 6808Janssen Research & Development, LLC, San Diego, CA, USA
| |
Collapse
|
5
|
Ramos MF, Baker J, Atzpodien EA, Bach U, Brassard J, Cartwright J, Farman C, Fishman C, Jacobsen M, Junker-Walker U, Kuper F, Moreno MCR, Rittinghausen S, Schafer K, Tanaka K, Teixeira L, Yoshizawa K, Zhang H. Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic). J Toxicol Pathol 2018; 31:97S-214S. [PMID: 30158741 PMCID: PMC6108092 DOI: 10.1293/tox.31.97s] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
Affiliation(s)
| | - Julia Baker
- Member of eye subgroup
- Charles River Laboratories, Inc., Frederick, MD, USA
| | | | - Ute Bach
- Member of eye subgroup
- Bayer AG, Wuppertal, Germany
| | | | | | | | - Cindy Fishman
- Member of eye subgroup
- Member of glands of the eye subgroup
- GlaxoSmithKline, King of Prussia, PA, USA
| | | | | | - Frieke Kuper
- Member of olfactory subgroup
- Retired; formerly The Netherlands Organization for Applied
Scientific Research (TNO), Zeist, the Netherlands
| | | | | | - Ken Schafer
- Member of eye subgroup
- Member of otic subgroup
- Vet Path Services, Inc., Mason, OH, USA
| | - Kohji Tanaka
- Member of eye subgroup
- Nippon Boehringer Ingelheim, Japan
| | | | | | | |
Collapse
|
6
|
Kurata M, Atsumi I, Yamagiwa Y, Sakaki H. Ocular instillation toxicity study: current status and points to consider on study design and evaluation. ACTA ACUST UNITED AC 2016. [DOI: 10.2131/fts.3.217] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- Masaaki Kurata
- Pharmacokinetics & Toxicology Research Laboratories, Senju Pharmaceutical Co., Ltd
| | - Ikuyo Atsumi
- Pharmacokinetics & Toxicology Research Laboratories, Senju Pharmaceutical Co., Ltd
| | - Yoshinori Yamagiwa
- Pharmacokinetics & Toxicology Research Laboratories, Senju Pharmaceutical Co., Ltd
| | - Hideyuki Sakaki
- Pharmacokinetics & Toxicology Research Laboratories, Senju Pharmaceutical Co., Ltd
| |
Collapse
|
7
|
Elmore SA, Cora MC, Gruebbel MM, Hayes SA, Hoane JS, Koizumi H, Peters R, Rosol TJ, Singh BP, Szabo KA. Proceedings of the 2014 National Toxicology Program Satellite Symposium. Toxicol Pathol 2014; 43:10-40. [PMID: 25385331 DOI: 10.1177/0192623314555526] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The 2014 annual National Toxicology Program (NTP) Satellite Symposium, entitled "Pathology Potpourri" was held in Washington, D.C., in advance of the Society of Toxicologic Pathology's 33rd annual meeting. The goal of this annual NTP Symposium is to present current diagnostic pathology or nomenclature issues to the toxicologic pathology community. This article presents summaries of the speakers' presentations, including diagnostic or nomenclature issues that were presented, along with select images that were used for audience voting and discussion. Some lesions and topics covered during the symposium included a pulmonary mucinous adenocarcinoma in a male B6C3F1 mouse; plexiform vasculopathy in Wistar Han (Crl:WI[Han]) rats; staging of the estrous cycle in rats and mice; peri-islet fibrosis, hemorrhage, lobular atrophy and inflammation in male Sprague-Dawley (SD) rats; retinal dysplasia in Crl:WI[Han] rats and B6C3F1 mice; multicentric lymphoma with intravascular microemboli and tumor lysis syndrome, and 2 cases of myopathy and vascular anomaly in Tg.rasH2 mice; benign thymomas in Crl:WI[Han] rats; angiomatous lesions in the mesenteric lymph nodes of Crl:WI[Han] rats; an unusual foveal lesion in a cynomolgous monkey; and finally a series of nomenclatures challenges from the endocrine International Harmonization of Nomenclature and Diagnostic Criteria (INHAND) Organ Working Group (OWG).
Collapse
Affiliation(s)
- Susan A Elmore
- National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA
| | - Michelle C Cora
- National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA
| | - Margarita M Gruebbel
- Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA
| | - Schantel A Hayes
- Charles River Laboratories, Pathology Associates, Durham, North Carolina, USA
| | - Jessica S Hoane
- Charles River Laboratories, Pathology Associates, Durham, North Carolina, USA
| | | | - Rachel Peters
- Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USA
| | | | - Bhanu P Singh
- Janssen Research & Development, Spring House, Pennsylvania, USA
| | - Kathleen A Szabo
- Charles River Laboratories, Pathology Associates, Durham, North Carolina, USA
| |
Collapse
|